Leilei Xia1, Colin D Sperling1, Benjamin L Taylor2, Ruchika Talwar1,3, Raju R Chelluri1, Jay D Raman4, Daniel J Lee1,3, David I Lee1, Thomas J Guzzo1. 1. Division of Urology, Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia. 2. Department of Urology, Weill Cornell Medicine, New York Presbyterian Hospital, New York, New York. 3. Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia. 4. Division of Urology, Department of Surgery, Pennsylvania State University College of Medicine, Hershey, Pennsylvania.
Abstract
PURPOSE: Robot-assisted radical prostatectomy has become the predominant surgical modality to manage localized prostate cancer in the U.S. However, there are few studies focusing on the associations between hospital volume and outcomes of robot-assisted radical prostatectomy. MATERIALS AND METHODS: We identified robot-assisted radical prostatectomies for clinically localized (cT1-2N0M0) prostate cancer diagnosed between 2010 and 2014 in the National Cancer Database. We categorized annual average hospital robot-assisted radical prostatectomy volume into very low, low, medium, high and very high by most closely sorting the final included patients into 5 equal-sized groups (quintiles). Outcomes included 30-day mortality, 90-day mortality, conversion (to open), prolonged length of stay (more than 2 days), 30-day (unplanned) readmission, positive surgical margin and lymph node dissection rates. RESULTS: A total of 114,957 patients were included in the study, and hospital volume was categorized into very low (3 to 45 cases per year), low (46 to 72), medium (73 to 113), high (114 to 218) and very high (219 or more). Overall 30-day mortality (0.12%), 90-day mortality (0.16%) and conversion rates (0.65%) were low. Multivariable logistic regressions showed that compared with the very low volume group, higher hospital volume was associated with lower odds of conversion to open surgery (OR 0.23, p <0.001 for very high), prolonged length of stay (OR 0.25, p <0.001 for very high), 30-day readmission (OR 0.53, p <0.001 for very high) and positive surgical margins (OR 0.61, p <0.001 for very high). Higher hospital volume was also associated with higher odds of lymph node dissection in the intermediate/high risk cohort (OR 3.23, p <0.001 for very high). CONCLUSIONS: Patients undergoing robot-assisted radical prostatectomy at higher volume hospitals are likely to have improved perioperative and superior oncologic outcomes compared to lower volume hospitals.
PURPOSE: Robot-assisted radical prostatectomy has become the predominant surgical modality to manage localized prostate cancer in the U.S. However, there are few studies focusing on the associations between hospital volume and outcomes of robot-assisted radical prostatectomy. MATERIALS AND METHODS: We identified robot-assisted radical prostatectomies for clinically localized (cT1-2N0M0) prostate cancer diagnosed between 2010 and 2014 in the National Cancer Database. We categorized annual average hospital robot-assisted radical prostatectomy volume into very low, low, medium, high and very high by most closely sorting the final included patients into 5 equal-sized groups (quintiles). Outcomes included 30-day mortality, 90-day mortality, conversion (to open), prolonged length of stay (more than 2 days), 30-day (unplanned) readmission, positive surgical margin and lymph node dissection rates. RESULTS: A total of 114,957 patients were included in the study, and hospital volume was categorized into very low (3 to 45 cases per year), low (46 to 72), medium (73 to 113), high (114 to 218) and very high (219 or more). Overall 30-day mortality (0.12%), 90-day mortality (0.16%) and conversion rates (0.65%) were low. Multivariable logistic regressions showed that compared with the very low volume group, higher hospital volume was associated with lower odds of conversion to open surgery (OR 0.23, p <0.001 for very high), prolonged length of stay (OR 0.25, p <0.001 for very high), 30-day readmission (OR 0.53, p <0.001 for very high) and positive surgical margins (OR 0.61, p <0.001 for very high). Higher hospital volume was also associated with higher odds of lymph node dissection in the intermediate/high risk cohort (OR 3.23, p <0.001 for very high). CONCLUSIONS:Patients undergoing robot-assisted radical prostatectomy at higher volume hospitals are likely to have improved perioperative and superior oncologic outcomes compared to lower volume hospitals.
Authors: Paul Baloche; Nicolas Szabla; Lucas Freton; Marine Hutin; Marina Ruggiero; Ines Dominique; Clementine Millet; Sebastien Bergerat; Paul Panayotopoulos; Reem Betari; Xavier Matillon; Ala Chebbi; Thomas Caes; Pierre-Marie Patard; Nicolas Brichart; Laura Sabourin; Charles Dariane; Michael Baboudjian; Bastien Gondran-Tellier; Cedric Lebacle; François-Xavier Madec; François-Xavier Nouhaud; Xavier Rod; Gaelle Fiard; Benjamin Pradere; Benoit Peyronnet Journal: Eur Urol Open Sci Date: 2022-02-08
Authors: Daniel D Shapiro; John W Davis; Wendell H Williams; Brian F Chapin; John F Ward; Curtis A Pettaway; Justin R Gregg Journal: BJUI Compass Date: 2021-09-27
Authors: Melanie A Lindenberg; Valesca P Retèl; Henk G van der Poel; Ferdau Bandstra; Carl Wijburg; Wim H van Harten Journal: Sci Rep Date: 2022-05-10 Impact factor: 4.996
Authors: Rebecka Arnsrud Godtman; Erik Persson; Walter Cazzaniga; Fredrik Sandin; Stefan Carlsson; Göran Ahlgren; Eva Johansson; David Robinsson; Jonas Hugosson; Pär Stattin Journal: PLoS One Date: 2021-06-17 Impact factor: 3.240